Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Angiology. 2015 Apr;66(4):339-45. doi: 10.1177/0003319714533588. Epub 2014 May 15.

Abstract

Reactive oxygen species have been implicated in the pathogenesis of contrast-induced nephropathy (CIN). We investigated the relationship between CIN with paraoxonase 1 (PON-1) activity and oxidative stress markers (total antioxidant status [TAS], total oxidant status [TOS], and oxidative stress index [OSI]) in patients with anterior ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention; 289 consecutive patients with STEMI were prospectively included. The patients were divided into 2 groups: CIN (n = 69) and non-CIN (n = 220). Activity of PON-1 and TAS levels were significantly lower and OSI and TOS levels were significantly higher in patients with CIN compared to the non-CIN group (P < .05, for all). On multivariate logistic regression analysis, PON-1 activity and OSI as well as the amount of contrast medium and diabetes were independent predictors for CIN in patients with anterior STEMI. Activity of PON-1 and oxidative stress may play a role in the pathogenesis of CIN.

Keywords: contrast; infarction; nephropathy; oxidative stress; paraoxonase.

MeSH terms

  • Adult
  • Aged
  • Anterior Wall Myocardial Infarction / blood
  • Anterior Wall Myocardial Infarction / diagnostic imaging
  • Anterior Wall Myocardial Infarction / enzymology
  • Anterior Wall Myocardial Infarction / therapy*
  • Aryldialkylphosphatase / blood*
  • Biomarkers / blood
  • Chi-Square Distribution
  • Contrast Media / adverse effects*
  • Coronary Angiography / adverse effects*
  • Diabetes Complications / chemically induced
  • Female
  • Humans
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / diagnosis
  • Linear Models
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Oxidative Stress*
  • Percutaneous Coronary Intervention / adverse effects*
  • Prospective Studies
  • Risk Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Contrast Media
  • Aryldialkylphosphatase
  • PON1 protein, human